Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » eTheRNA

eTheRNA

ADVERTISEMENT
News and Trends

Millions in funding and new board members for Belgian mRNA company

The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…

By Liza Laws
August 24, 2022 - 3 minutes
In Depth

How can vaccines keep up with evolving Covid-19 variants?

Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened…

By Jonathan Smith
July 28, 2022 - 7 minutes
News and Trends

Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry

Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…

By Anita Chakraverty
June 15, 2021 - 5 minutes
News and Trends

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic…

By Helen Albert
June 18, 2020 - 3 minutes
In Depth

Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?

The first vaccine against coronavirus disease could one day be made of mRNA. How is…

By Jonathan Smith
March 30, 2020 - 7 minutes
News and Trends

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…

By Clara Rodríguez Fernández
December 11, 2018 - 3 minutes
News and Trends

Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma

eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…

By Clara Rodríguez Fernández
June 30, 2017 - 2 minutes
Interview

Infographic: Who’s who in the mRNA Therapeutics Field in Europe?

The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…

By Clara Rodríguez Fernández
April 26, 2017 - 1 minute
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days